Government has mandate for NHS reform, says Dorrell
July 8, 2010NHS, government
In return for ringfencing the NHS’s budget, the government now has a strong mandate for reforming health services, says the …
Pharming forges production deal with Sanofi Chimie
July 8, 2010Manufacturing and Production, Sales and Marketing HAE, Pharming, Ruconest, Sanofi Chimie
Dutch biotechnology group Pharming has signed a toll manufacturing agreement with Sanofi Chimie in order to boost commercial-scale manufacturing of …
Dr Eliseo Salinas joins Elan
July 8, 2010Research and Development Elan, appointment, research and development
Elan has appointed Dr Eliseo Oreste Salinas as executive VP and chief medical officer with responsibility for leading the company’s …
NICE poised to reject Novartis’ Afinitor
July 8, 2010Sales and Marketing Afinitor, NICE, Novartis
Novartis’ kidney cancer drug Afinitor does not offer enough benefit to patients to justify its cost, according to draft guidance …
Digital Pharma: Big pharma’s iPhone apps (part three)
July 7, 2010Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone
In the first two parts of Big Pharma’s iPhone Apps I looked at apps produced by 11 of the largest …
Roche submits new version of Herceptin for US approval
July 7, 2010Research and Development, Sales and Marketing Herceptin, Roche, breast cancer
Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …
EMA panel advises Fabrazyme switch
July 7, 2010Manufacturing and Production Fabrazyme, Genzyme, manufacturing compliance
Doctors in Europe have been told they should consider switching patients with Fabry disease away from treatment with Genzyme’s Fabrazyme …
Italy plans cancer drug price cut
July 7, 2010Sales and Marketing Italy, economic climate, global pricing, price cuts, pricing
Italy will cut drug prices next year as it adopts a ‘pay for performance’ approach to drug pricing. This will …
George Scangos to head up Biogen
July 7, 2010Research and Development Biogen, appointment, research and development
Biogen Idec has appointed George Scangos chief executive officer, with effect from 15 July. Scangos will join the company from …
4Sight launches conference division
July 7, 2010Medical Communications, Sales and Marketing 4Sight, Performance Meetings, sales and marketing
UK pharma commercial services company 4Sight has launched a conference division. The Bracknell, UK-based firm’s Performance Meetings division will be …
European scrutiny of pharma patent deals to continue
July 6, 2010Sales and Marketing European Commission, competition, patents
Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …
Bind Biosciences appoints Dr Ed Schnipper
July 6, 2010Manufacturing and Production, Research and Development Bind Bioscience, appointment, manufacturing and production, research and development
US biopharmaceutical company Bind Biosciences has appointed Dr Ed Schnipper as chief medical officer. Dr Schnipper joins the company with …
NICE set to block Herceptin for gastric cancer
July 6, 2010Sales and Marketing Herceptin, NICE, Roche, gastric cancer
NICE’s preliminary draft guidance has not approved Roche’s Herceptin for gastric cancer as it failed to show how far the …
NHS slow to tackle health inequalities
July 6, 2010NHS, NHS targets
The NHS has not moved quickly enough to tackle inequalities in life expectancy in areas with the worst health and …
More woe for Genzyme as shipping delays continue
July 6, 2010Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance
Genzyme is expecting further delays in shipments of two key products as it struggles to bring its troubled Allston Landing …
Pharma manufacturing news in brief
July 6, 2010Manufacturing and Production BMS, Borregaard Synthesis, Colorcon, JHP Pharma, Saltigo, Sanofi-Aventis, Synthetech, Viropharma, univar
New capital investments from Sanofi-Aventis, Bristol-Myers Squibb, Viropharma and Colorcon head up this round-up of developments in the pharmaceutical manufacturing …
Digital Pharma: Big pharma’s iPhone apps (part two)
July 5, 2010Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone
Part one of Big Pharma’s iPhone Apps covered apps produced by Pfizer, Merck & Co, GlaxoSmithKline, Sanofi-Aventis and Novartis and …
AstraZeneca collaborates on compound library
July 5, 2010Research and Development AstraZeneca, MRC
AstraZeneca and the UK’s Medical Research Council are to share access to their compounds to improve their efforts to find …
Margot James: Tories to ‘nudge’ change in NHS
July 5, 2010Medical Communications, Sales and Marketing NHS, government, pm society
Speaking to the industry for the first time since being elected as Conservative MP for Stourbridge at the recent General …
Lilly set to acquire Alnara Pharmaceuticals
July 5, 2010Research and Development, Sales and Marketing Alnara, Liprotamase, cystic fibrosis, enzyme replacement therapy, lilly
Lilly is to acquire US-based biotech firm Alnara and will take hold of its lead product Liprotamase for pancreatic enzyme …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
